The Journal of the Iowa Pharmacy Association is a peer-reviewed publication. Authors are encouraged to submit manuscripts to be considered for publication in the Journal. For author guidelines, see www.iarx.org/journal
“The Journal of the Iowa Pharmacy Association” (ISSN 15257894) publishes 3 issues per year: January/February/March/ April issue; May/June/July/August issue; and September/ October/November/December issue by the Iowa Pharmacy Association, 2570 106th Street, Unit D, Urbandale, IA 50322.
POSTMASTER: Send address changes to: The Journal of the Iowa Pharmacy Association, 2570 106th Street, Unit D, Urbandale, IA 50322. Published tri-annually, The Journal is distributed to members as a regular membership service paid for through allocation of membership dues. Subscription rates are $80 per year, single copies are $30. Printed by Mittera; Graphic design by the Iowa Pharmacy Association.
Gratitude
Jim Hoehns, PharmD, BCPS, FCCP
2024-2025 IPA President
Clinical Associate
Professor, UI College of Pharmacy, Ambulatory Care Preceptor, Cedar Valley Primary Care
“
“I think Iowa is a special place... I could fill pages with examples of kindness…Isn’t that itself remarkable?”
This May, our youngest child, Jack, graduated from high school at Dike-New Hartford (DNH). As one might expect when your youngest prepares to leave home, I’ve spent some time reflecting. I am a proud father of three wonderful children; my wife, Barb, and I have so many things to be thankful for.
We moved into the DNH school district in 2005— what a wonderful place for our children to receive their education. I am grateful for the amazing teachers, coaches and school workers in our community. I am also thankful for all the students and their parents. I am certainly biased, but it is easy to be excited for the future with such a great group of young people beginning their adult journeys.
We go to church in Dike, and I am thankful for our church friends and neighbors. They have been a great influence on our family. I am thankful for the entire DNH community.
I’m thankful for all the outstanding pharmacists, physicians, nurses and coworkers I continue to work with and have worked with over the years. I enjoy working with student pharmacists, and I am grateful for all my interactions with them. I am thankful for the patients who have shared their joys and concerns and entrusted me and my students to play a part in their care. I often tell students they may forget many things I have taught them over time, but they will likely remember the patients they were able to help—and I think that is true.
As the Iowa Pharmacy Association’s CEO, Kate Gainer, winds down her tenure with IPA, I am
grateful for her tremendous leadership over the past 14 years. When you really listen to Kate, when she shares her perspective or an expression of kindness or support, it is amazing how thoughtful and genuine of a person she is. She has been truly invested in advancing pharmacy in Iowa and is an amazing leader for our profession. Thank you, Kate, for everything. I am also thankful for the remarkable staff at IPA. We could not be more fortunate than to have the likes of Laura, Allison, Kellie, Brian, Amanda, Dawn, and our incoming CEO, Matt Pitlick.
Just a few weeks ago, Governor Reynolds signed SF 383 (PBM reform) into law. I am thankful for all the pharmacists and patients across Iowa who shared their stories and advocated for this important legislation. I am also thankful for Dr. Michael Andreski’s work in sharing important information about pharmacy closures across Iowa. This was a crucial message for pharmacists in Iowa to share.
I think Iowa is a special place. I have been blessed to meet and interact with so many genuinely good people over the years. I could fill pages with examples of kindness which have been demonstrated to me personally along with others. Isn’t that itself remarkable? Yet, we probably too often take it for granted.
As you can tell, this spring, I really have had an overwhelming sense of gratitude. I hope you can take a few minutes to reflect on things in your life you are thankful for also. Thank you for your support of IPA. ■
Below: IPA advocating for SF 383 (Matt Eide, Kate Walton, Jim Hoehns, Wes Pilkington, Kate Gainer, Maddy Bradley)
A Love Letter to IPA
Kate Gainer, PharmD
Executive Vice President & CEO, Iowa Pharmacy Association
Although we don’t say it out loud, I believe true leadership is an act of love. Through reading past IPA Journals, annual reports, performance reviews, previous editorials, and looking at pictures, I’ve taken time to reflect on my 14 years as CEO and 20 years with the organization. The best way I could write my final CEO editorial is a love letter to IPA.
Dear IPA,
In 2011, I began my journey as IPA’s CEO with deep admiration for the profession of pharmacy and leadership in our state. I knew it was both a tremendous opportunity, and a tremendous responsibility, to be selected as CEO and to carry forward IPA’s legacy of collaboration, innovation, and strength.
It’s easy to reflect on recent achievements, including: passing meaningful PBM reform in Iowa; modernizing the Iowa Pharmacy Practice Act to full pharmacist practice authority and the standard of care regulatory framework; moving IPA’s headquarters to a modern space and selling the old office; strengthening IPA and the IPA Foundation’s finances; and supporting pharmacists, student pharmacists, and technicians through the ever-evolving landscape of healthcare.
But we must not forget the challenges faced together. It was in these difficult moments that I saw the very best of IPA: unwavering resilience, passion, and a community that always shows up for one another. Whether it was facing legislative roadblocks, responding to natural disasters, or the immense demands of a global pandemic, we stood strong—together. As CEO of IPA, I learned quickly how to fail forward. And you supported me in taking risks, trying new things, brushing off the setbacks and always looking to the future.
For me, the most meaningful moments came between the highs and lows. The moments that aren’t always documented but will remain in my heart as highlights of this journey. The hugs and tears behind the House of Representatives gallery after the passage of SF 383; the board retreats filled with vision and laughter; the letters nominating IPA members for state and national recognition; the hallway conversations; the opportunity to support IPA staff; and the quiet pride of watching members grow into leaders. Through these moments, I found not only colleagues but lifelong friends.
Serving as IPA’s CEO has been the greatest honor of my professional life. You’ve watched me, and my family, grow up during my tenure of leadership. And I’ve watched pharmacists not only grow into leaders but also become more deeply embedded in patient care teams, always showing up with compassion, knowledge, and purpose.
I leave this role with gratitude, love, and an unwavering belief in the power of IPA, our membership, and staff team. IPA is more than a professional association—it is a community bound by a fierce desire to leave the profession better than we found it and a shared mission and values. To me, these core values have been the love language of IPA.
Thank you for letting me lead, learn, and grow alongside you. I will forever be your biggest champion.
With love,
Fuel Exam Confidence
with Official PTCB Practice Tools
Candidates using PTCB’s Practice Tools consistently report higher passing rates, giving them the confidence to soar.
Employers and educators can easily support candidates by
Leadership in Transition: A New Era for IPA and Iowa Pharmacy
In November, Kate Gainer, PharmD, Executive Vice President & CEO of the Iowa Pharmacy Association since 2012, announced her plans to step down as CEO, effective June 2025. Following a five-month nationwide search by the IPA Search Committee and IPA Board of Trustees, Matthew Pitlick, PharmD, BCPS, was selected to lead the association as its next Chief Executive Officer. Pitlick began as Incoming CEO on April 28, 2025, allowing for a brief overlap with Kate before the 2025 IPA Annual Meeting.
Matthew “Matt” Pitlick will serve as IPA’s ninth CEO since its founding in 1880. Pitlick earned his PharmD from Drake University College of Pharmacy and Health Sciences and served as clinical faculty at the University of Health Sciences and Pharmacy in St. Louis, MO, for eight years before returning to his home state of Iowa. No stranger to IPA, Pitlick completed IPA’s one-year Executive Fellowship in Association Management in 2018-2019. Pitlick brings a wealth of pharmacy leadership expertise with experience in association management, academia, industry, and health system practice.
With new leadership at the helm, IPA staff sat down with Kate and Matt to discuss the transition and their visions for the future of the profession.
Kate Gainer and Matt Pitlick at ASHP Midyear 2018
KATE GAINER
As you reflect on your time as IPA’s CEO, what are some of your proudest accomplishments?
» Passing meaningful PBM reform in 2025, and the hugs and tears that were shared outside the House gallery on May 12, 2025.
» Modernizing Iowa’s Pharmacy Practice Act and serving as a national leader in the standard of care regulatory framework and full practice authority for pharmacists.
» Serving in national leadership roles and representing IPA through NASPA (Board and Past President), PACE Alliance (Vice President), and PMG (Treasurer).
» Selling the IPA headquarters and right-sizing operations for the future.
» Building new programs when opportunity was present, such as CPESN Iowa, the IPA Executive Fellowship, and RAGBRAI teams.
» Creating three endowments within the IPA Foundation (Temple Leadership, Bill Burke, and Outcomes Innovative Endowment).
» Elevating others—at IPA we capture every opportunity to elevate and recognize leaders in Iowa pharmacy. Celebrating Iowa pharmacists always brings great pride.
» Lastly, I’m proud of the work culture we’ve created at IPA. We have implemented policies that put people first—from staff sabbaticals to mental health days, summer schedules and flexible work. Through this positive culture, we are accountable to one another, communicate clear expectations and support each other as whole humans. Each member of the team cares greatly about IPA.
What’s next for you? How will you continue to be involved in the profession?
With great intention, my next step is to hit “pause.” Throughout my twenty-year career at IPA, I've focused on work-life integration, and a professional pause is part of that journey. This summer, our four children will be 14, 12, 10 and 10, and it is an opportunity for me to lean into my family and deepen those relationships.
I will remain IPA’s strongest supporter, cheering from the sidelines instead of being in the arena. I look forward to attending IPA events with even more opportunities for deep connection with other Iowa pharmacists. Eventually, I will un-pause or hit “play” again. In my heart, I believe there is more I can contribute professionally; however, I’m not putting an exact timeline on that.
Is there anyone you would like to thank as you prepare to leave IPA?
Tom Temple. I wouldn’t be in this position today had Tom not seen something in me that translated into leadership potential. And I could never have lasted in this position for fourteen years without the lessons I learned from Tom.
Each and every past president. Those that served before me and supported me and IPA through the CEO transition fourteen years ago; as well as each president I've had the opportunity to partner with in serving the profession.
My husband, Bob. A strong support system is mission-critical to serving as the CEO of IPA. I would not have applied for this position without his encouragement, as I was nervous about becoming a CEO and having our first child in the same year. And his support was unwavering through the years.
MATT PITLICK
What are your goals for the association within your first year as CEO?
In my first year, my goal is to listen deeply, build trust, and set a strong foundation for the future. I want to elevate the visibility of our members, strengthen relationships with stakeholders, and ensure IPA is leading on workforce, reimbursement, and practice innovation issues, particularly around our new standard of care Pharmacy Practice Act. I’m also focused on sustainability and growing member value in practical, meaningful ways.
LEADERSHIP TRANSITION
MATT PITLICK (Cont.)
Where do you see the profession of pharmacy headed?
Pharmacy is at a crossroads. We are moving to an integrated, patient-centered model where pharmacists are fully recognized as providers. Technology and AI will reshape how we manage medications, workflows, and patient engagement—but they won’t replace the trust, empathy, and expertise pharmacists and technicians bring. If we lean into innovation while holding firm to our values, we can lead this transformation rather than react to it.
What are you most excited about in your new role as IPA’s CEO?
I’m most excited about shining a spotlight on the amazing work Iowa pharmacists and pharmacy teams are doing every day, and making sure policymakers, payers, and the public see it too. I also look forward to building bridges across all practice settings, listening to members’ needs, and helping shape a bold, unified vision for where pharmacy is headed. There’s something special about Iowa pharmacy—we have tradition, talent, and tenacity, and I’m energized to help tell that story and push it forward.
How can IPA members support you through this transition?
Stay engaged. Reach out. Tell me what’s working, what’s frustrating, and where you see opportunities. I believe the best ideas come from our members. We’re in this together.
What else would you like Iowa pharmacy professionals to know about you?
I’m a dad, husband, coach, teacher and pharmacist, and I care deeply about this profession. Outside of work, I love playing guitar, watching and coaching baseball with my son, and yes…I’m a lifelong pro wrestling fan. (I’ve learned a lot of leadership and life lessons, seriously!) I believe in grit, humor, and getting things done. You’ll always know where I stand, and I’ll always stand with you. ■
(L) First day as IPA Executive Fellow, (R) First day as IPA CEO
Historic Progress for Iowa Pharmacy: PBM Reform (SF 383) Signed Into Law
IPA’s top legislative priority in 2025 to pass a meaningful PBM reform bill was achieved on June 11, 2025. A culmination of four legislative sessions, this monumental victory was only possible with the support of IPA members who engaged in grassroots advocacy, amplified our efforts on social media, attended legislator town halls, and activated their patient networks—this session and years prior.
A new strategy in 2025, IPA hired a public relations firm to amplify our message beyond the statehouse. The PR campaign, which began in August 2024, led to 100+ media stories through print and digital newspapers, social media, AM radio, and TV outlets across the state related to SF 383, highlighting pharmacy closures and the urgent need for the state legislature to take action and reform PBM practices in Iowa.
2025 Session Highlights
IPA and a coalition of supporters worked together to ensure alignment in support of PBM reform in the state. Members of this PBM coalition included IPA, Hy-Vee, Independent Pharmacy Cooperative (IPC), Iowa Hospital Association (IHA), MercyOne, and the Healthcare Distribution Alliance (HDA).
January 29 — Representative Brett Barker introduced HSB 99. Senator Mike Klimesh introduced the companion bill, SSB 1074.
February 5 — IPA gathered over 200 members at the state capitol for its 2025 Pharmacy Day on the Hill. IPA hosted a PBM reform press conference led by Kate Gainer (IPA CEO), Wes Pilkington (IPA President-elect and pharmacy owner) and Randy McDonough (APhA President-elect and pharmacy owner). Both HSB 99 and SSB 1074 passed out of subcommittee with IPA members in attendance.
March 6 — Senator Michael Bousselot introduced SSB 1207, claiming it was a pro-business PBM bill that would support rural and independent pharmacies as well as define pharmacy deserts. With less than 18 hours’ notice, IPA Champion Advocates, as well as Board and Legislative Committee members, mobilized to oppose SSB 1207. The alternate bill passed out of
Letter written to Governor Reynolds by Wes Pilkington’s son, Jacob
subcommittee (3-0) and was on the full Commerce Committee agenda later that day. IPA members in the districts of senators on the Commerce Committee sent emails, text messages and phone calls urging a NO vote on SSB 1207. The bill was never brought for a full committee vote, signaling enough senators spoke up in caucus that they would not support the bill.
April 8 — IPA called on members to show up at the state capitol for a PBM Day of Action to personally meet with state senators and representatives. Nearly 50 IPA members attended, making their voices heard in support of PBM reform.
April 28 — SF 383 passed the Iowa Senate (36-14) on mostly party lines, following a failed amendment introduced by Senate Democrats. Three Democrats voted for the bill, and three Republicans voted against it.
May 12 — At 7:00 am Monday morning, IPA hosted a PBM Reform Rally on the day the Iowa House was scheduled to debate the PBM bill. Over 100 pharmacists, pharmacy owners, technicians, and patients showed up to gather on the east steps of the state capitol building. As legislators entered the building, IPA members caught their attention and thanked them for their support of PBM reform and access to local pharmacy care. The energy was positive, the sun was shining, and legislator support was palpable.
Nearly 50 pharmacists stayed and continued advocating inside the building as the House Republicans went into caucus. It was well known that an alternative amendment—bad for pharmacy—was being introduced and debated in the caucus. With many pharmacists and pharmacy owners waiting in the hallway, the caucus rejected that amendment. Throughout the day, members left to return home as the House Democrats were approached to introduce the same alternative amendment that had been rejected by Republicans. IPA members, both inside the building and at home, contacted their representatives throughout the day.
At approximately 6:00 pm, the House finally called SF 383 for debate. Nearly 20 IPA members were still in the building watching from the House gallery. SF 383 passed the Iowa House (75-15). Following the vote, pharmacists gathered outside the House gallery and shared hugs, handshakes and tears of gratitude for the bill’s passage.
May 15 — The Iowa Legislature adjourned in the early morning hours, sending bills to Governor Reynolds for her to take action on within 30 days. Throughout this period of waiting for the Governor’s signature, IPA continued to amplify our message and member voices through letters to the editor, as well as radio and TV interviews.
IPA collected more than 250 handwritten letters to Governor Reynolds, requesting her signature on SF 383 with personal stories of the impact the bill would have. IPA also reached out to patient advocacy and healthcare provider groups to send a letter to the Governor, urging her signature on SF 383. 19 statewide organizations signed on.
June 5 — During the 2025 IPA Annual Meeting, IPA had the opportunity to meet in person with Governor Reynolds and her staff. This meeting was attended by Kate Gainer (CEO), Wes Pilkington (less than an hour after his installation as IPA President), Kelly Kent (pharmacy owner and IPA Board member) and Charlie Hartig (CEO of Hartig Drug and 2025 Champion Advocate). During this meeting, IPA presented the Governor with all hand-written letters and spoke of the urgency and importance of signing SF 383 into law.
June 11 — Governor Reynolds signed SF 383 into law and published a thoughtful statement on her decision.
The Opposition
Throughout the legislative session, prominent groups opposed SF 383. On the list of official lobbyist declarations, 18 groups (42 lobbyists) were registered in support, whereas 31 groups (62 lobbyists) were registered in opposition and actively working to defeat the bill throughout each step of the legislative process. Immediately following the House vote to pass SF 383, a joint press release was issued by the bill’s opponents, calling for the Governor to veto the bill, claiming it would cost Iowa businesses $340 million.
The Road to PBM Reform
Iowa’s first PBM bill passed in 2007. Since that time, the association has worked continuously to improve the landscape of PBM practices in Iowa for both patients and pharmacies through education, policy, and advocacy.
In 2014, a comprehensive PBM reform bill was passed and signed into law by Governor Branstad and was legally challenged by the Pharmaceutical Care Management Association (PCMA). PCMA v Gerhart was ultimately appealed to the 8th Circuit in 2017; the bill and its definitions were found to be in violation of ERISA, effectively striking the entirety of the legislation and removing Iowa’s regulatory authority.
In 2020, the Supreme Court of the United States upheld an 8th Circuit decision (PCMA v Rutledge) with a unanimous decision that states do have the authority to regulate PBM pricing practices, and such matters are not preempted by ERISA.
Following the Rutledge decision, IPA brought forward comprehensive PBM reform legislation to the Iowa legislature in 2022. However, at the final hour, IPA changed its registration to ‘opposed,’ as the original language was continually compromised to remove the meaningful provisions in the bill.
Through both 2023 and 2024, different strategies were employed to pass PBM legislation, but during both legislative sessions, the Iowa House of Representatives passed meaningful bills only to encounter opposition in the Senate, failing to garner a Senate vote. However, the education of lawmakers by IPA members and the momentum built in 2022, 2023, and 2024 paved the way for SF 383 to pass both the Iowa Senate and Iowa House in 2025. ■
2025 Standard of Care Symposium & Leadership Summit
Over 180 pharmacy professionals from across the country attended the first-ever Standard of Care Symposium in West Des Moines on February 22, 2025. The keynote address, delivered by Jennifer Adams, PharmD, EdD, FAPhA, FNAP, Associate Dean for Academic Affairs at Idaho State University, outlined how standard of care can transform pharmacy practice.
Attendees heard an update on the new Iowa Board of Pharmacy rules from Executive Director Anne Schlepphorst. A special presentation was delivered
by Tim Frost, PharmD, Senior Fellow at the Cicero Institute, on the path towards pharmacist full practice authority. Additional topics included liability and risk management, billing and payment for services, the employer perspective and more, making for an informative, energetic day.
On Sunday, February 23, nationwide leaders were invited to attend a Leadership Summit for those pursing standard of care in their respective states. The one-day summit equipped attendees with bold ideas and strategies to
Jennifer Adams
Where Do We Go from Here? Resources for Your Practice:
• Updated Standard of Care FAQ Guide: www.iarx.org/SOC_FAQ
achieve pharmacist full practice authority using the standard of care framework. 41 pharmacy leaders from 18 different states were in attendance (Right)
Following the symposium, IPA redesigned its Member Forums to further these discussions and continue helping pharmacy professionals navigate this new landscape. During each ‘Standard of Care Conversation,’ IPA staff collected questions and topics to guide the 2026 symposium, scheduled for Saturday, January 31st. ■
• IPA Goes Local: Implementing Iowa’s Pharmacy Standard of Care: From Framework to Practice
• Des Moines — August 21, 2025
• Black Hawk/Bremer County — September 18, 2025
• Spencer — October 2, 2025
• Dubuque — October 9, 2025
• Iowa City — November 6, 2025
• IPA Member Forums: Standard of Care Conversations
• Standard of Care Symposium — January 31, 2026
Tim Frost
Cardiovascular Health Improvement Grant –
IPA Goes Local
The Cardiovascular Health Improvement Grant, in its second year, focuses on improving cardiovascular health and reducing health disparities, particularly related to hypertension and high cholesterol. This grant is in collaboration with the Iowa Department of Health and Human Services’ Bureau of Chronic, Congenital and Inherited Conditions and is funded by the National Cardiovascular Health Program and Centers for Disease Control and Prevention (CDC).
IPA continues to build momentum with active engagement from the first cohort, with participating pharmacies in the early stages of implementing their quality improvement projects. In efforts to address social service needs and support this high-risk population, each project leverages one of the following: health information systems, utilizing multidisciplinary teams, enhancing community clinical partnerships, or supporting training for pharmacy technicians as community health workers.
Chayla Morris, PharmD, BCACP, IPA member and Ambulatory Care Clinical Pharmacy Coordinator at Broadlawns Medical Center, is leading the reporting efforts of this grant as an Ambulatory Care Advisor for IPA. Initial data collection is underway, and early insights are helping to shape the infrastructure needed to support pharmacists in ambulatory care settings.
IPA’s Goes Local programming is supported in part by this grant. This year’s program, “Implementing Iowa’s Pharmacy Standard of Care: From Framework to Practice,” provides a high-level overview of the framework, outlines key changes impacting pharmacy practice, and explores practical strategies for integrating the standard of care into patient care management for both acute and chronic health conditions.
As part of the IPA Goes Local events held in April and May, Chayla contributed insights on the potential of the standard of care framework to enhance patient outcomes, particularly in the management of heart disease. She illustrated this impact through examples demonstrating how the framework can be effectively applied throughout the patient care process.
Advancing Public Health: HIV/HCV Prevention Meetings
IPA staff attended the 2025 HIV and Hepatitis Prevention and Ryan White Part B Contractor’s Meeting in Coralville in April. This two-day conference was hosted by the NuCara Capacity Building Extension Program. (NuCara is an independent contractor of the Bureau of HIV, STI, and Hepatitis of Iowa Health and Human Services.) IPA has contracted with Iowa HHS since 2018, advancing a grant focused on HIV and HCV testing in community pharmacies.
The new Bureau Chief, Biz McChesney, gave a state of the state address on the latest HIV, STI and HCV infections. Biz also touched on the national landscape and grant cuts from the federal level. She outlined how the state receives funding and stated they are not anticipating being impacted by the changes that have occurred at the federal level.
Other breakout sessions focused on accessibility of PrEP and PEP, exploring collaborations when addressing opioid overdose, and informal opportunities to share strategies, best practices and lessons learned related to engaging communities in HIV and HCV prevention and testing services.
HIV & HCV Testing Project Quarterly Meeting
Pharmacies participating in the HIV/HCV Testing Project met virtually in May. Iowa HHS staff presented a session focused on improving STI outcomes through EPT in pharmacies, and Gilead Sciences’ Senior Medical Scientist also attended to share the latest innovations in HIV prevention with their new PrEP options.
IPA remains in constant communication with our partners at Iowa HHS related to any executive orders at the federal level that may impact IPA’s grant funding.
Iowa HHS Pharmacy Bag Campaign: Ask Us About Vaccines
At the end of 2024, Iowa Health and Human Services contracted with IPA to administer a project promoting vaccine awareness. Between January and April 2025, IPA distributed nearly 2 million pharmacy bags to over 350 pharmacies across the state. Pharmacies that received bags include: CPESN Iowa Network, MercyOne inpatient and outpatient pharmacies, Hy-Vee pharmacies, Medicap and NuCara pharmacies. Whether the bags sparked a question about vaccines or simply started a conversation, these pharmacies helped put public health directly into patients’ hands!
Investing in the Future of Pharmacy: Searching & Submitting Grants
IPA staff have been actively pursuing grant opportunities to support and advance the pharmacy profession, with several successful applications already underway. IPA focuses on identifying and applying for funding that aligns with the strategic plan set by IPA’s Board of Trustees and the interests of our members. If you are interested in participating in any grant initiatives or are looking to collaborate on grant opportunities, please contact Kellie Staiert (kstaiert@iarx.org), IPA’s Director of Grants & Partnerships, to explore potential opportunities.
PRACTICE ADVANCEMENT
Key Elements for Pharmacy Technician Scope of Authority –NASPA Workgroup
IPA was invited to participate as a state leader on a workgroup convened by NASPA (National Alliance of State Pharmacy Associations) in 2025. The workgroup aims to establish a best practice framework for pharmacy technician scopes of authority across the United States, providing clarity, consistency, and enhanced utilization of pharmacy technicians in patient care.
As Iowa and IPA are recognized as national leaders in advancing pharmacy technician roles and scopes, we were invited to share our expertise on policy related to pharmacy technicians. Kate Gainer, PharmD, served as IPA’s representative to this national workgroup.
The ‘Key Elements for Pharmacy Technician Scope of Authority” workgroup is supported by the Community Pharmacy Foundation (CPF) and Pharmacy Technician Certification Board (PTCB).
DEA Stalls Pharmacist CSA Registration Despite Law Change
When Iowa passed HF 555—the modernized Iowa Pharmacy Practice Act—on July 1, 2024, it opened the door for pharmacists to obtain individual Controlled Substances Act (CSA) registration, which would allow them to prescribe controlled substances. This was especially significant for treating patients with substance use disorder (SUD), where pharmacist involvement can greatly improve access to care and patient outcomes.
Despite the law granting clear authority, the U.S. Drug Enforcement Administration (DEA) has yet to respond to months of outreach from the Iowa Board of Pharmacy and the Iowa Attorney General’s Office. Without DEA recognition, pharmacists cannot register under the CSA, making the new prescribing authority effectively unusable.
The Iowa Board of Pharmacy continues to push for federal engagement, but the process remains stalled. Until the DEA acts, Iowa pharmacists are unable to provide the full range of care authorized under state law—leaving patients in need and progress halted.
Payer Update: IPA Advances Reimbursement Readiness Ahead of New Practice Rules
As Iowa prepares to implement new administrative rules (IAC 481) under the standard of care regulatory framework, IPA has been proactively laying the groundwork to ensure pharmacist-provided services are appropriately recognized and reimbursed.
Strategic Collaboration with Key Stakeholders
IPA collaborated with Iowa Medicaid to identify both current pharmacist services provided under IAC 657 and those anticipated under the new framework that are not yet billable. This initiative is a critical step toward aligning payment models with the clinical services pharmacists are ready to provide, particularly for Medicaid patients.
Member Feedback Highlights Reimbursement Challenges
At the 2025 Payment for Pharmacy Services Forum in April, pharmacists highlighted persistent reimbursement barriers:
• Prescription Transfers Blocked by Billing Concerns: Pharmacists reported that other pharmacies often reject transfers due to reimbursement uncertainty, limiting patient access—especially in rural areas.
• CPT Code Confusion: Multiple CPT codes are used for the same service, such as immunizations, with little guidance. This inconsistency leads to billing errors and rejections.
• Need for a Pharmacist-Focused Billing Guide: Members called for a Medicaid-specific guide to clarify code definitions, use scenarios, and align pharmacist billing with that of other providers.
Push for Medication Safety Intervention Reimbursement
Pharmacists regularly perform high-value, non-billable safety interventions, such as preventing adverse drug events and resolving drug interactions. IPA is advocating for a new billing category to capture and reimburse this critical work.
Expanding Billing Flexibility and Provider Recognition
Members raised concerns about billing restrictions with Evaluation and Management (E/M) codes, which often prevent pharmacists from billing for services like immunizations concurrently. IPA is urging Iowa Medicaid to allow similar billing flexibility as physicians and to explore designating pharmacists as Qualified Health Providers (QHPs) for services like Chronic Care Management (CCM) and Remote Physiologic Monitoring (RPM).
Addressing Adherence Packaging Gaps
Pharmacies providing adherence packaging to large patient populations—often at MCO request—currently must charge patients out of pocket. IPA is advocating for this to become a Medicaid-reimbursable service to improve adherence and affordability.
Drake CPHS Celebrates 129 Professional Program Graduates at 2025 Commencement Ceremony
The College of Pharmacy and Health Sciences (CPHS) held its annual Professional Hooding and Commencement Ceremony for professional program students on Friday, May 16, 2025. The CPHS Bachelor of Science in Health Sciences undergraduate students participated in the University Undergraduate Commencement Ceremony held on Saturday, May 17th.
Receiving their degrees and doctoral hoods during the CPHS Hooding and Commencement Ceremony were:
40 Occupational Therapy Doctoral (OTD) students
67 Doctor of Pharmacy (PharmD) students
7 Master of Athletic Training (MAT) graduates
10 Master of Health Informatics & Analytics (MSHIA) graduates
5 Master of Clinical Psychopharmacology (MSCP) graduates
The Hooding and Commencement Ceremony included reflections from three of the graduating student government representatives. Mackenzie Laughlin (OTD), Kayla Batdorf (PharmD), and Darinka Stepan (MAT) congratulated their peers and wished them luck in the next chapter of their careers.
“We’re stepping into a world that needs us. A world where people of all ages and backgrounds face barriers to living fully,” Laughlin said. “But we know how to help. We’ve been trained not just in assessments and interventions, but in empathy, creativity and resilience.”
These students also led their classes through the Oath of an Occupational Therapist, the Oath of an Athletic Trainer, and the Oath of a Pharmacist.
Drake University Provost Sue Mattison conferred the degrees. CoraLynn Trewet, PH’03, welcomed the graduates into the Drake CPHS alumni network.
“Today, you are going to take home a degree. But it’s not about what you take in life, it’s about what you give,” Trewet said. “So, what do you have to give? Go give it. Give them your all.”
Pharmacy graduate awards were announced at a P4 Success Symposium and Celebration held the day prior, including the following award recipients:
• Anna Holden – Viatris Excellence in Pharmacy Award
• Jacob Miller – Russell Johnson Outstanding Community Practice Graduate Award
• Anna Braun – Merck Royal Society of Chemistry Certificate of Excellence
• Kaitlyn Thomas – Jerry L. Karbeling Memorial Leadership Award ■
Kayla Batdorf
Dean Erik Maki
Credit: Drake CPHS
PharmD Class of 2025 Commencement
Eighty-four University of Iowa (UI) Doctor of Pharmacy students were hooded May 15 at the Class of 2025 commencement. On the day prior, a special celebration honored graduates and recognized their achievements.
Academic excellence awards went to Sarah Hou, Courtney Schenkelberg, Cole Ludolph, and Kaley Wolff. Meghan Schick earned a United States Public Health Service Award nomination, while Samantha Ritter was a Hancher Finkbine Award nominee. As the 2024-25 national American Pharmacists Association (APhA)-Academy of Student Pharmacists (ASP) Speaker of the House, Stephen Presti also was spotlighted.
Additional Notable Achievements:
• Students Receiving a Combined Doctor of Pharmacy/Master's of Health Informatics Degree: 1
• Students Receiving a Combined Doctor of Pharmacy/Master’s of Public Health Degree: 2
• Students Receiving a Leadership Certificate: 1
• Students Receiving a Certificate in Palliative Care: 7
• Percentile of Students Graduating with Highest Distinction: 11%
• Students Receiving ExCEL Cords (Excellence in Community Engagement, Leaders, and Service): 40
• Students Participating in Health Care Business Leadership: 20
• Students Graduating as First-Generation Students: 27
• Students Matching with a PGY1 Residency Program: 43
• ASHP Residency Match Rate: 96%
Varied Paths
The college spoke with six graduates—two each who chose employment, fellowship, or residency—to learn why they selected pharmacy and their career path, what was challenging and memorable about their PharmD education, and how their time at Iowa prepared them for post-graduation plans.
Employment
Porter Hummel will begin his PharmD career working as a community pharmacist with Booth Pharmacy in Hawarden, Iowa, and part owner of Kingsley Drug in Kingsley, Iowa. Hummel was given the opportunity to purchase a pharmacy with good friend Connor Clark, ’24 PharmD, and another pharmacist from his hometown.
“I always knew I wanted to go directly into the job market and work alongside my dad, who has owned and operated a pharmacy for 40 years. Dad worked with and learned from his father,” said Hummel. “The time I spend with him and learning from him will be invaluable and I couldn’t be more excited.”
Serving community patients is why Hummel continued the pharmacy legacy, having cared for them since age 16. “There is no greater feeling in my eyes than knowing your patient trusts you to give them the best care they can possibly receive and that you are accessible to them,” he said.
During pharmacy school, Hummel’s biggest obstacle was the pace. “(There was) a lot of beneficial and necessary material to take in and gain mastery-level knowledge of so I can take care of my patients,” he said. “Learning to balance the demands of school, such as therapeutics courses with exams every week, while keeping up with life in general was (hard).” Studying all night at the college for 8:00 a.m. exams is something he’ll always hold in his mind, said Hummel, adding that in the end, it was all worth it.
“The experiences and opportunities we were given, as well as the environment in which we learned, set me up for career success,” he said. “It is truly a family atmosphere at the UI College of Pharmacy, and everyone is willing to help each other be the best they can be. My friends and I also had plenty of fun together and played trivia every Tuesday night at Quinton’s in Iowa City.”
Grady Orwig is beginning a pharmacy staff position at Hy-Vee in Ottumwa, Iowa. He said he wants to establish himself as a good pharmacist and has always wanted to help people. “I did well in chemistry in high school and wanted to go into the medical field. I toured the UI College of Pharmacy and decided to go into pharmacy.”
Orwig noted that he picked immediate employment in community pharmacy because he knew it was the job he wanted. “Residency did not appeal to me from a financial or location standpoint,” he said. “I also wanted to return to my hometown with my family and my fiancée.”
According to Orwig, because high school and most undergraduate schoolwork came easily to him, he developed terrible study habits. “That did not help me when I was challenged in pharmacy school. I had to fix it.”
CLASS OF 2025
He recounted among his best memories arriving at the college early before tests with his friends for last-minute review sessions. “We would quickly go over our notes and quiz each other as well as try and guess what would be on the tests,” he said.
All the effort paid off, giving him knowledge necessary to be a pharmacist, Orwig reflected. “But more importantly, it has given me the skills needed to keep improving and serving my patients.”
Fellowship
Anthony Medina is heading to a Pharmacy Informatics and Supply Chain Leadership PGY2 fellowship at Vizient Inc. in Chicago. Medina first became interested in pharmacy through weightlifting. He was fascinated by how supplements, like creatine, branched-chain amino acids, and pre-workout, interact with the body. That interest eventually evolved from gym supplements to pharmaceuticals and the broader impact they can have on health.
Medina decided to pursue an industry fellowship because of the opportunities for long-term professional growth and the ability to make a broader impact on health care. Securing it gave him clarity and purpose during the most challenging part of pharmacy school, his final year.
“Frequently switching (Advanced Pharmacy Practice Experiences) rotations made it difficult to maintain momentum or feel a sense of continuity,” Medina said. “From the point I received the fellowship forward, I began viewing each rotation as a valuable opportunity to gain experience and develop skills that would support my future goals.”
Medina noted that while the UI College of Pharmacy gave him a “strong clinical foundation,” it was his involvement in the Industry Pharmacists Organization and the Healthcare Business Leadership Program that helped shape his career path. “The experiences introduced key topics in industry and leadership, allowing me to explore areas beyond traditional pharmacy practice,” he said.
Medina continued, “While clinical care focuses on individual patients, this path allows me to contribute at a systems level, improving processes, driving innovation, and shaping the future of pharmacy practice on a larger scale. I hope to gain a deeper understanding of the root causes behind many of today’s healthcare challenges and explore potential solutions.” He added he is also looking forward to expanding his knowledge in areas such as 340B drug pricing, contract negotiations, and data analytics.
Looking back on his past four years of school, Medina noted his favorite memories are the relationships he made. “Whether it was a golf outing, or early morning study sessions before exams, I appreciated having a few solid people to share the experience with and connections that will carry on after graduation,” he said.
Emily Weyenberg is moving to Washington, D.C., to be an APhA Board of Pharmacy Specialties fellow. “I have always been passionate about the nontraditional side of pharmacy. Through involvement in various pharmacy organizations, I saw the powerful impact they have on students and the profession,” Weyenberg said. “I hope to build the skills needed to address challenges in pharmacy while effectively communicating and advocating for legislative advancements. I want to help drive broad-scale change, advance pharmacy practice, and ensure pharmacists are empowered to provide the highest level of patient care.”
In fact, it was pharmacy’s influence on patient care that attracted Weyenberg to the field. “Pharmacists play a crucial role in health care, impacting patients in many ways,” she said, adding that the networking opportunities available through the UI College of Pharmacy, alongside her pharmacy organizations involvement, helped prepare her for the association career route.
Weyenberg noted balancing her dedication to and leadership in those organizations with coursework was difficult. “With only so many hours in the day, strong time-management skills were needed to stay on top of all commitments,” she said. “I quickly learned the importance of prioritizing tasks, maintaining open communication, and staying organized. Asking for help when needed was also key to managing responsibilities effectively.”
When reminiscing about her four-year PharmD education, a happy memory is serving in regional and national roles with APhA-ASP. “My experience at Iowa made those opportunities possible and helped shape the direction of my pharmacy career,” Weyenberg said. “Through these roles, I met inspiring student pharmacists from across the country and significantly grew skills that will continue to guide my future.”
Residency
Jason Lin will soon be a PGY1 general resident with AdventHealth Shawnee Mission in a Kansas City suburb. “I pursued a residency because it aligns with my career goals and commitment to patient-centered care. I want to work in an environment where patients are truly seen as individuals,” said Lin. “I hope to gain valuable clinical and professional skills and strengthen my time-management, clinical, and decision-making skills—key components of effective care.”
Lin selected the pharmacy profession after growing up translating medical visits for his parents, helping them navigate hospitals and pharmacies. “I saw how hard it was for them to understand and access care, and I want to be that bridge— someone who helps people like them feel informed, safe, and supported in their healthcare journey,” he said.
According to Lin, the UI College of Pharmacy’s fast-paced, detailed curriculum prepared him well for the boards and his career. “The rigorous academics, combined with supportive, highly qualified faculty, made the experience both challenging and enjoyable,” he said.
Balancing rigorous APPE rotations while applying for postgraduate opportunities was the most difficult part of Lin’s PharmD education. “I overcame it by setting clear goals, prioritizing tasks, and integrating them into my schedule,” he said. “Staying organized made a huge difference and taught me the value of structure and time management, which continues to help me succeed.”
As he transitions from student to pharmacist, Lin takes with him fond recollections of his time at Iowa. “Meeting new people and making new friends (was memorable). I (also) really enjoyed my time at events, such as the pharmacy ball and PDC events, and I even had some time to travel internationally to different places in Asia.”
Lucy Sundrup has accepted a PGY1 general residency at CHI Health Creighton University Medical Center–Bergan Mercy out of Omaha, Nebraska. Sundrup explained that pursuing pharmacy combined her love of science with patient care. “I wanted a role where I could make a direct impact on health outcomes, advocate for patients, and be a lifelong learner in an ever-evolving field,” she said.
She added her PharmD schooling readied her for a residency by “providing strong clinical training, interprofessional experiences,
and leadership opportunities that built my confidence, critical thinking, and communication skills.” During her education, Sundrup found it tough to balance multiple responsibilities. “I overcame it by prioritizing tasks, setting realistic goals, and seeking support from peers and mentors when needed.”
Sundrup selected the residency path to further bolster her clinical assuredness, manage complex cases, and prepare for a PGY2 residency in oncology. “Residency offers the structure and support to grow as an independent and confident clinical pharmacist,” she said.
Attending the APhA Annual Meeting is something Sundrup especially liked about pharmacy school. “It helped me build connections with peers and professionals while expanding my knowledge of the pharmacy field,” she said. ■
Credit: UI College of Pharmacy
2025 Pharmacy Day on the Hill & PBM Day of Action
Nearly 200 pharmacists, student pharmacists, and pharmacy technicians engaged in face-to-face grassroots advocacy at Pharmacy Day on the Hill on February 5, 2025, in Des Moines. IPA members met one-on-one with Iowa legislators to communicate pharmacy’s priorities and the dire need for PBM reform.
IPA hosted a PBM reform press conference, welcoming members of the media to the capitol to hear the truth about PBMs from Iowa pharmacists and phar-
macy owners, as well as how the public feels about PBM reform. IPA presented poll data demonstrating 80% of Iowa voters agree it is important that the state legislature take action to address PBMs, and 70% say the state legislature should consider PBM reform to be “must-pass legislation” in 2025.
In addition, the PBM bill was heard in both House and Senate subcommittees. Pharmacists in white coats filled the rooms, providing powerful testimony in support of reform. With the passage
of IPA’s top legislative priority out of subcommittee, the press conference and a well-attended legislator reception, this Day on the Hill was the liveliest to date!
The 2025 Good Governance Award, recognizing an Iowa legislator who supports pharmacy and healthcare issues, was presented to Representative Matt W. Windschitl (District 15). The Legislative Champion Award, recognizing an IPA member who has made significant contributions to IPA’s advocacy efforts, was presented to Charlie Hartig, PharmD, JD.
Hartig was a powerful advocate during the 2024 Legislative Session and helped get the modernized Iowa Pharmacy Practice Act (HF 555) to the finish line.
In addition, nearly 50 Iowa pharmacists took to the state capitol for our PBM Day of Action on April 8, 2025. Impactful conversations were had with legislators in the House and Senate, as members emphasized the urgency of passing SF 383 to protect patient access and save Iowa pharmacies. ■
PBM Reform Press Conference
2025 Legislative Champion Award
Testimony by Cory Garvin
PUBLIC AFFAIRS
2025 Iowa Legislative Recap
The 2025 Iowa Legislative Session concluded in the early hours of May 15, 2025. Throughout the session, IPA registered on a total of 21 bills impacting the pharmacy profession and monitored many more internally.
Prior to session, IPA's Legislative Committee proposed, and the Board of Trustees approved, four legislative priorities.
IPA Priorities
PBM Reform
Last summer and fall, IPA launched a targeted grassroots campaign led by 2024-2025 Executive Fellow George Appleseth, mobilizing members across the state and using patient stories and pharmacy data to bring PBM reform to the forefront of the legislative agenda. Over 20 in-district pharmacy visits with legislators highlighted the damaging impact of practices like patient steering, below-cost reimbursement, and network discrimination. These visits were bolstered by data from the 2024 Iowa Community Pharmacy Survey, which revealed a staggering trend: most pharmacies reported being reimbursed below the cost of drug acquisition on more than 40% of prescriptions, with some as high as 80%.
As the 2025 session began, with persistent grassroots engagement and strategic legislative advocacy, PBM reform became one of the top issues at the capitol. Senate File 383, a comprehensive PBM reform bill, advanced through the Iowa Senate after significant delays and debate, ultimately passing as amended by a vote of 36-14. The bill then moved to the Iowa House of Representatives, where it passed without further amendment by a 75-15 vote. Governor Reynolds signed SF 383 into law on June 11, 2025. This historic legislation marks a turning point in Iowa’s fight for fair pharmacy practices, enacting sweeping changes that will protect patients, stabilize pharmacies, and bring much-needed transparency to the prescription drug supply chain.
Fund Iowa Medicaid Pharmacy Reimbursement
In early 2025, Governor Kim Reynolds’ proposed budget included an appropriation for Medicaid prescription reimbursement that aligned with the latest results of the COD survey. However, as the session progressed, significant cuts to healthcare funding at the federal level, coupled with fiscal constraints at the state level, led to the removal of this increase from the final budget bill. IPA will continue to prioritize this issue in the years ahead. With many pharmacies—especially in rural communities—operating on razor-thin margins, ensuring fair reimbursement through Medicaid is essential to keeping pharmacy doors open and maintaining access to care for Iowa’s most vulnerable patients.
Protect the 340B Drug Pricing Program
As pharmacy access becomes increasingly threatened across the country, the 340B Drug Pricing Program remains a lifeline for many patients and communities in Iowa. Designed to allow covered entities to stretch scarce federal resources and expand services to underserved populations, the 340B program continues to face growing threats from PBMs, drug manufacturers, and potential federal budget cuts.
During the 2025 Iowa Legislative Session, IPA remained steadfast in its support of protecting the integrity and viability of the 340B program. While IPA did not introduce specific 340B legislation this year, the association proudly registered in support of a 340B-focused bill introduced by Representative Brett Barker in the House. Unfortunately, the bill did not advance past the first legislative funnel. However, its introduction represents a meaningful step forward in drawing attention to the urgent need for state-level protections.
Rural Healthcare Workforce
In a year marked by ongoing concerns about pharmacy closures and growing healthcare deserts across Iowa, IPA elevated a new legislative priority: supporting the rural healthcare workforce. Central to this priority is investing in the development of future pharmacists through expanded residency training and loan repayment opportunities that attract providers to underserved communities.
During session, IPA registered in support of Governor Kim Reynolds’ rural healthcare initiative, House File 754 and Senate File 575. These companion bills proposed major investments to address Iowa’s healthcare workforce shortages, including those impacting rural areas. The legislation sought to consolidate Iowa’s five separate student loan repayment programs and increase their funding from $4.2 million to $10 million. It would have expanded eligibility to individuals trained out-of-state who commit to practicing in high-need Iowa communities for five years.
The bill also included plans to add an estimated 115 new medical residency slots at Iowa teaching hospitals, with a goal of leveraging up to $150 million in federal matching funds. This expansion would have been supported by state matches from the University of Iowa and Broadlawns Medical Center. Despite broad support from Iowa’s healthcare advocates, the legislation did not survive the session. Supporting the rural healthcare workforce remains a top priority for IPA in the years ahead.
Federal Regulatory Update PUBLIC
HHS Announces Major Restructuring
The U.S. Department of Health and Human Services (HHS) has announced a restructuring plan intended to streamline operations, reduce costs, and improve public health response. The plan includes a workforce reduction from 82,000 to 62,000 employees, consolidation of 28 divisions into 15, and reduction of regional offices from 10 to 5. Key functions like Human Resources, IT, Procurement, External Affairs, and Policy will be centralized.
Agency-Specific Changes:
• FDA: Reduces 3,500 positions, focusing on administrative functions while maintaining core review and inspection roles.
• CDC: Reduces 2,400 positions, refocusing on epidemic preparedness. The integration of ASPR into the CDC will enhance coordination.
• NIH: Cuts 1,200 positions through centralization of procurement and HR functions.
• CMS: Reduces 300 positions to eliminate redundancies, with no impact on Medicare or Medicaid services.
New Structures:
• Administration for a Healthy America (AHA): Consolidates key agencies to better coordinate chronic care and disease prevention programs.
• Office of Strategy: Merges ASPE and AHRQ to enhance policy research and program evaluation.
• Assistant Secretary for Enforcement: Oversees compliance functions to reduce waste, fraud, and abuse.
• ACL Realignment: Distributes ACL programs across ACF, ASPE, and CMS to improve service delivery for older adults and individuals with disabilities.
PBM Oversight Intensifies
FTC Case Resumes
FTC Chair Andrew Ferguson has lifted his recusal in a key case accusing PBMs of rebate manipulation in insulin pricing. The case had been stalled following commissioner shakeups and legal challenges involving former Democratic appointees.
Attorneys General Push for PBM Reform
A bipartisan group of 39 state attorneys general is urging Congress to ban PBMs from owning pharmacies, citing anticompetitive risks. Iowa Attorney General Brenna Bird did not sign on to the letter.
PBM Transparency Act Reintroduced
Senators Cantwell and Grassley have reintroduced legislation to increase transparency and curb deceptive PBM practices, with projected savings of $740 million.
FTC-Directed PBM Study Proposed
The reintroduced Prescription Pricing for the People Act would require the FTC to examine how PBMs affect pricing, steer patients, and leverage proprietary data.
President Trump’s Latest Health Care Appointments: Key Nominations for Top U.S. Health Agencies
Dr. Susan Monarez has been nominated to permanently lead the CDC after serving as acting director and deputy director at ARPA-H. Her nomination follows the withdrawal of Dr. Dave Weldon. President Donald Trump has also nominated health entrepreneur Casey Means as U.S. Surgeon General, replacing Dr. Janette Nesheiwat. Means, a Stanford-trained physician and co-founder of the glucose monitoring company Levels, is an advocate for the “Make America Healthy Again” (MAHA) agenda, which emphasizes addressing chronic disease through environmental and dietary changes. Her appointment aligns with Secretary Robert F. Kennedy Jr.’s vision to challenge the pharmaceutical and food industries. Dr. Nesheiwat’s nomination was withdrawn amid questions about her credentials and allegations of misrepresenting her medical degree.
In 2025, IPA launched a new fundraiser to support the Iowa Pharmacy Political Action Committee (IPPAC) and pharmacy’s advocacy agenda. IPA members and friends of pharmacy donated $25 to fill out a bracket for the Men’s and Women’s NCAA Tournaments. Cash prizes were paid out to the top three finishers in each bracket. Over 80 brackets were submitted, raising $1,400 for the IPPAC. The Men’s Tournament winner was Josh Roehrick, and the Women’s Tournament winner was Mike Pursel.
MEN’S:
1st: Josh Roehrick
2nd: Bill Drilling
3rd: Mike Schweitzer
WOMEN’S:
1st: Mike Pursel
2nd: Dawn Morse
3rd: Jennifer Simmons
Healthcare Hot Topics
Affordability Challenges & Solutions for GLP-1s in Diabetes Care
The affordability of diabetes medications such as GLP-1s has been a significant barrier for patients since these agents entered the market, despite their therapeutic effectiveness. The Inflation Reduction Act, implemented this year, provides support through Medicare Part D prescription drug coverage. While it sets an out-of-pocket cap of $2,000 for prescription drug costs, this cap may still be insufficient for patients living below the poverty line to access their diabetes medications. Pharmacies can play a key role in bridging this gap and improving medication adherence.
Patient assistance programs (PAPs), offered by manufacturers, allow eligible patients to receive brand-name diabetes medications at no cost. A breakdown of each manufacturer and the medications they offer can be found on the Pharmacy Times® website (“Cost-Effective Pharmacotherapy for Patients With Diabetes”). Another resource pharmacists can utilize to help patients afford their medications includes manufacturer savings cards or prescription coupons. Understanding eligibility criteria for each of these savings tools is critical to identifying the appropriate support for each patient.
Redefining CKD Management: Key Updates in KDIGO’s Latest Clinical Guidelines
The Kidney Disease: Improving Global Outcomes (KDIGO) organization has updated its clinical practice guidelines for the evaluation, management, and treatment of chronic kidney disease (CKD), addressing both adults and children who are not receiving kidney replacement therapy. These guidelines emphasize personalized care based on factors such as sex, genetics, physiology, and socio-economic background, recognizing that CKD progression and treatment responses differ among individuals. The guidelines also acknowledge global disparities in healthcare access and highlight the importance of tailored strategies depending on resource availability.
The updated guidelines include 28 recommendations and 141 practice points, with a focus on evidence-supported practices like using cystatin C for glomerular filtration rate assessment,
point-of-care testing in remote areas, and employing sodiumglucose cotransporter-2 (SGLT2) inhibitors and statins to improve kidney and cardiovascular health in CKD patients. While the guidelines recommend these therapies, they also highlight challenges such as the underrepresentation of certain populations in clinical trials and gaps in evidence for optimal treatment. They call for more inclusive research and novel study designs to improve CKD care globally.
Recent studies have demonstrated that administering a single dose of the 20-valent pneumococcal conjugate vaccine (PCV20) to toddlers who have previously received doses of the 13-valent PCV (PCV13) significantly enhances protection against additional pneumococcal serotypes. This approach effectively broadens the immune coverage beyond what was achieved with PCV13 alone.
The Advisory Committee on Immunization Practices (ACIP) has endorsed the use of PCV20 in children, recommending it as an option for routine immunization in children aged 2 through 23 months. They also suggest its use for catch-up vaccination in older children with incomplete PCV vaccination histories. These recommendations aim to provide comprehensive protection against a wider array of pneumococcal serotypes, addressing the evolving landscape of pneumococcal disease threats.
Measles Returns: CDC Issues Travel and Vaccination Guidance
As of July 15, 2025, a total of 1,309 confirmed measles cases have been reported across 40 states. Of the reported cases this year, 29% involve children under the age of 5, 37% are individuals between 5 and 19 years old, 34% are adults aged 20 or older, and the ages of 1% are unknown. Notably, 92% of these cases either involved individuals who were unvaccinated or whose vaccination status is unknown. A majority of the reported measles cases have occurred in Texas (700+).
The Centers for Disease Control and Prevention (CDC) has issued an updated Health Alert Network (HAN) advisory to inform the public and health officials about the ongoing measles out-
break. The CDC has provided guidance on prevention and monitoring through the summer travel season, stressing the critical role that clinicians and public health officials play in preventing the spread of measles, primarily through vaccination. Anyone presenting with a febrile rash that meets the case definition for measles, particularly those who are unvaccinated, should be educated in effective measles prevention strategies. The Measles-Mumps-Rubella (MMR) vaccine remains the most effective tool for preventing infection and the spread of the measles. All U.S. residents should be up to date on their MMR vaccination before international travel, regardless of their destination.
The Pharmacist’s Role in Managing Iron Deficiency Anemia in Heart Failure
As research advances, the critical role of clinical pharmacists in optimizing care for patients with heart failure is becoming increasingly evident, particularly in the management of iron deficiency. Iron deficiency affects approximately 50% of patients with heart failure, with prevalence rising to 80% during acute
decompensations. A recent Pharmacy Times® article highlights emerging evidence that serum iron concentration and transferrin saturation (TSAT) may be more closely associated with prognosis than serum ferritin alone. Iron deficiency anemia is present in roughly 30% of stable heart failure patients and up to 50% of hospitalized patients, compared to less than 10% in the general population.
While anemia management guidelines have evolved, oral iron supplementation remains ineffective in this population due to limited absorption. Intravenous (IV) iron formulations are the preferred approach but introduce clinical challenges such as variable dosing strategies, risk of infusion reactions, hypophosphatemia, and access barriers related to formulary restrictions.
In this complex landscape, inpatient clinical pharmacists are well-positioned to lead therapeutic decision-making. They play a key role in evaluating iron parameters, coordinating transitions of care, and tailoring IV iron dosing regimens. By providing patient-specific assessments and addressing barriers to access, pharmacists can significantly improve anemia management and overall outcomes in patients with heart failure.
2024-2025 IPA Foundation Scholarships
Drake University
Eggleston-Granberg Scholarships
Stacia Humphrey
Mike & Terry Pursel Scholarship
Sophia Bell
Russell E. Johnson Jr. & Lucille Johnson Scholarship
Alexander Frank
Thomas & Cathy Temple Scholarship
Stacy Johnson
General Scholarships
Deena Alsabbah
Kayla Batdorf
Lexie Bennett
Alya Danabasoglu
Kaitlyn Thomas
Christopher Decker Pharmacy Scholarship
Abigail Axell
The University of Iowa
Eggleston-Granberg Scholarships
Andrew Schemmel
Mitchell Schemmel
Thomas & Cathy Temple Scholarship
Sabrina Renner
General Scholarships
Volta Adovor
Hannah McMurrin
Megan Schreur
Christopher Decker Pharmacy Scholarship
Stephen Presti
L to R: Kate Gainer, Cathy Temple, Stacy Johnson, Sabrina Renner, Stephen Presti
Dive into the personal stories of pharmacy leaders and innovators who are redefining the healthcare landscape. Each month, IPA sits down to hear what ignited these leaders’ passion for pharmacy, as well as discuss challenges, triumphs and lessons learned along the way. Get ready to embark on an inspiring, thought-provoking, and trailblazing adventure! www.iarx.org/trailblazers
What, Why & How
Unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Iowa Board of Pharmacy. Each month, IPA welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice. www.iarx.org/wwh_podcast
Emerging Leaders
Presented by IPA, PSW and TPA, this podcast is designed for leaders at all ages and levels! Recent topics include interprofessional education, pharmacy technician career lattices, creating high-performing teams and succession planning, networking myths and misconceptions, and more. www.iarx.org/emerging_leaders
www.iarx.org/podcasts
IPA Welcomes Brian Wall as Vice President of Professional Affairs
In May, IPA welcomed its new Vice President of Professional Affairs, Brian Wall, PharmD, CAE. Brian earned his PharmD from Drake University College of Pharmacy and Health Sciences in 2014. In 2015, he completed the APhA Foundation’s Executive Residency in Association Management & Leadership. Prior to this role, Brian worked for APhA for over ten years, most recently serving as Senior Director of Governance & Foundation Programs.
IPA Names Spencer Short as 20252026 Executive Fellow
IPA welcomes Spencer K. Short, PharmD, as the association's ninth Executive Fellow in Association Management. Spencer is a graduate of Ohio Northern University, with minors in Public Health, Medical Humanities, and Biomedical Sciences. As IPA’s Executive Fellow, Spencer will support the work of the association, gaining experience in leadership, advocacy, professional affairs and problem-solving, starting June 23, 2025.
IPA Names Volta Adovor as 2025 Executive Intern
IPA welcomes Volta Adovor, a 2027 PharmD candidate at the University of Iowa College of Pharmacy, as the 2025 Max W. Eggleston Summer Executive Intern. As IPA’s Executive Intern, Volta will gain experience in all aspects of association work and a broad exposure to the issues impacting the profession. Through early August, Volta will work on a variety of projects related to advancing IPA’s strategic plan and the IPA Foundation’s mission.
2025 IPA Member Forums: Standard of Care Conversations
This year’s IPA Member Forums facilitated “Standard of Care Conversations,” allowing pharmacy professionals to share successes and concerns related to the new Iowa Pharmacy Practice Act and regulatory framework. With seven forums held across practice settings, these sessions focused on practical strategies to streamline workflows, expand preventative care, and optimize pharmacy team roles under the evolving standard of care framework.
Attendees heard from early adopters and leaders in value-based care, who shared insights on service expansion, Medicaid billing opportunities, and collaboration with health systems. The forums also highlighted training and professional development pathways needed to support this transition. As implementation
nears, IPA will continue to equip members with the tools, resources, and advocacy to succeed in this new era of pharmacy practice.
APhA2025 – Iowa Pharmacy Prominent on National Stage
Iowa pharmacists were well represented at the 2025 APhA Annual Meeting in Nashville, TN, March 21-24.
Iowa Pharmacy Recognition
Randy McDonough, PharmD, MS, BCGP, BCPS, FAPhA, was installed as APhA President (Top) Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES, was awarded the APPM Distinguished Achievement in Service Award. Additionally, Stevie Veach, PharmD, BCACP, received the Anne Burns Community Pharmacy Residency Excellence Award, and Tze Ning Hiew, PhD, received the Ebert Research Prize (Bottom) Student pharmacists were also recognized, with Stephen Presti (UICOP P4) serving as APhA-ASP’s Speaker of the House, and Amisha Tayal (Drake P4) and Emily Weyenberg (UICOP P4) serving on APhA-ASP’s Communications National Standing Committee.
APhA House of Delegates
The APhA House of Delegates debated and adopted policy related to: pharmacy jurisprudence competency assessment; advancing health equity; ensuring patient access to pharmacy services and quality products by combating organized retail crime (ORC); critical access pharmacy model; the pharmacists’ role in intimate partner violence; shared clinical decision making for immunizations; regulation of pharmacy receptors; sustainability in pharmacy; and protecting pharmacists’ rights to provide evidence-based health information. Thank you to John Hamiel, PharmD; Jim Hoehns, PharmD, BCPS, FCCP; Kelly Kent, PharmD; Steve Firman, BS Pharm, MBA; and Connie Connolly, PharmD for representing Iowa at the APhA House of Delegates.
Iowa Reception
IPA, Drake University College of Pharmacy and Health Sciences, and the University of Iowa College of Pharmacy hosted a well-attended evening reception honoring the current and past leaders of our profession in the state of Iowa.
Iowa welcomed Deans Erik Maki and Jill Kolesar to their first ‘Iowa Reception’ in their roles as Dean and said farewell to Kate Gainer with her final reception as IPA CEO.
Presidential Reception & Pharmacy Flash Mob
IPA was a sponsor of the APhA Closing Reception honoring President Randy McDonough, and Kate Gainer shared a toast
with remarks highlighting Randy’s leadership. In addition to the APhA reception, IPA hosted a special event to honor Randy. As a gift, over 100+ pharmacists, family, and friends surprised Randy with a ‘pharmacy flash mob’ to the song “This is Me” from The Greatest Showman. It was a fitting way to celebrate Randy, as he has continually stepped out of his comfort zone to push his practice and the pharmacy profession forward—those attending were willing to step out of their comfort zones too. (And, Randy dreamed of a pharmacy flash mob to this exact song!) Sponsors of this event included IPA, the University of Iowa College of Pharmacy, McKesson, Independent Pharmacy Cooperative, Seguridad, CPESN-Iowa, and Towncrest Pharmacies.
Member Milestones
Best of luck to Craig Ford, PharmD, in his new role as Regional Director of Ambulatory Pharmacy at MercyOne!
Best of luck to Suzanne Feeney, PharmD, in her new role as Senior Director of Pharmacy Solutions at McKesson!
Congratulations to Kate Smith, PharmD, BCACP, who has been accepted into the University of Iowa Center for Teaching Scholarship of Teaching and Learning (SoTL) program!
Congratulations to Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES, who was recognized as the Mentor of the Year by Drake CPHS!
Congratulations to Rachel Digmann, PharmD, BCPS, who was promoted to Population Health Pharmacy Supervisor at MercyOne!
Best of luck to Megan Myers, PharmD, in her new role as a Compliance Officer with the Iowa Board of Pharmacy!
Congratulations to Darla Eastman, PharmD, who was recognized as the Faculty Preceptor of the Year by Drake CPHS!
Congratulations to Capstone Pharmacy, named Small Business of the Year Finalist in Mount Pleasant, IA!
Congratulations to Jennifer Alexander, PharmD, who received Drake CPHS’ IPPE Preceptor of the Year Award!
Congratulations to Mary Ray, BS Pharm, PharmD, who was awarded AACP’s 2025 Assessment SIG Collaborative Research Publication Award!
Congratulations to Emily Vyverberg, PharmD, who was inducted into the University of Dubuque’s Faculty Hall of Fame for Excellence in Teaching and Advising!
Congratulations to Sharlett Patterson, CPhT, Pharmacy Manager at Hy-Vee in West Des Moines, who was recognized as a Hero of the Heartland by the American Red Cross!
Best of luck to Nathan Peterson, PharmD, in his new role as Regional Manager of Clinical Pharmacy Services at UnityPoint Health!
In Memoriam
IPA is saddened to share the passing of Allen Fann, a past honorary president (2006-2007) and longtime supporter of IPA. Allen attended Drake University and established Fann Pharmacy in Atlantic in 1970. He later worked at Cass County Memorial Hospital and was recognized with IPA’s Health-System Pharmacist of the Year Award in 2000. Allen passed on March 25, 2025.
Pharmacy Flash Mob
Onnen Company has been serving our customers’ needs since 1964. Fourth generation owned and operated, we offer endless industry knowledge through dedicated sales reps, management and owners with well over 100 years combined experience. We have a knowledgeable, unparalleled, and dedicated customer service staff to help you through the order process. Thank you for trusting us to continue to serve your prescription packaging and pharmacy supply needs.
19 Issues
FEBRUARY:
87
& Events That Have Shaped Iowa Pharmacy (Or Are Fun To Remember!)
• New Iowa Medicaid reimbursement maximum allowed charge defined by Average Wholesale Price (AWP) — 10.59% plus professional fee of $5.01.
MARCH:
• FDA approved the first antiretroviral drug, zidovudine (AZT), for the treatment of HIV/AIDS.
• Prescription Drug Marketing Act (PDMA) was passed by the U.S. Congress.
APRIL:
• New requirements for pharmacy licenses were outlined in Chapter 215.
MAY:
• IPA member Gary Albers was selected to participate in the William S. Apple Memorial Program in Community Pharmacy Management.
JUNE:
• Jim Wallace received IPA’s first Distinguished Young Pharmacist of the Year Award at the Annual Meeting in Des Moines.
JULY:
• The 1986 revised Iowa Pharmacy Practice Act was enacted.
SEPTEMBER:
• FDA approved the first statin, lovastatin.
OCTOBER:
• FDA Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) were formed.
NOVEMBER:
• FDA approved alteplase for the treatment of myocardial infarction (MI).
DECEMBER:
• FDA hosted a workshop on opioid packaging, storage and disposal.
• Greenwood Pharmacy opened in Waterloo.
The Iowa Pharmacy Association Foundation is committed to the preservation of the rich heritage of pharmacy practice in Iowa. By honoring and remembering the past, we are reminded of the strong tradition we have to build upon for a prosperous future for the profession.
National Museum of American History
FDA
Protect your bottom line and reputation with Pharmacists Mutual.
These days, it sometimes seems impossible to protect your pharmacy from the unexpected. But when you partner with the industry experts at Pharmacists Mutual, you get peace of mind with a personalized policy that’s custom fit for your business and budget.
Insurance coverage is developed by industry experts including on staff pharmacists who know the value of your work, and most importantly, understand the business behind it.
